Oculis Holding AG - OCS
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 27, 2026 | SCHEDULE 13G/A | BVCF IV, L.P. | 4.14% | 2,436,902 | View |
| Mar 27, 2026 | SCHEDULE 13G/A | BEYEOTECH | 4.14% | 2,436,902 | View |
| Mar 27, 2026 | SCHEDULE 13G/A | BVCF IV GP, Ltd. | 4.14% | 2,436,902 | View |
| Mar 27, 2026 | SCHEDULE 13G/A | Zhi Yang | 4.14% | 2,436,902 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Nan Fung Group Holdings Limited | 4.9% | 2,815,476 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | NF Investment Holdings Limited | 4.9% | 2,815,476 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Nan Fung Life Sciences Holdings Limited | 4.9% | 2,815,476 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | NFLS Platform Holdings Limited | 0.9% | 514,702 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | NFLS Beta Limited | 0.9% | 514,702 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Pivotal Life Sciences Holdings Limited | 4.0% | 2,300,774 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Pivotal Partners Ltd | 4.0% | 2,300,774 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Pivotal bioVenture Partners Fund I U.G.P. Ltd. | 4.0% | 2,300,774 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Pivotal bioVenture Partners Fund I G.P., L.P. | 4.0% | 2,300,774 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Pivotal bioVenture Partners Fund I, L.P. | 4.0% | 2,300,774 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.